Loading clinical trials...

Electrical Stimulation for the Relief of Freezing of Gait (FOG) in Parkinson's Patients | Clinical Trials | Clareo Health

UNKNOWNNA

Electrical Stimulation for the Relief of Freezing of Gait (FOG) in Parkinson's Patients

Electrical Stimulation for the Relief of Freezing of Gait (FOG)

NCT01970891•National University of Ireland, Galway, Ireland

View on ClinicalTrials.gov

Summary

Potential for electrical stimulation to ameliorate Freezing of Gait (FOG)

Detailed Description

The purpose of this study is to investigate the potential for an electrical stimulation intervention to ameliorate Freezing of Gait (FOG) and related gait disturbances in Parkinson's patients.

Eligibility

Age

40 - 85 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•A diagnosis of idiopathic Parkinson's Disease (PD) (UK, PD Brain Bank Criteria)
•A Hoehn and Yahr stage of 2 - 4
•Exhibiting Freezing of Gait or another gait abnormality in the ON state.
•An ability to mobilise independently with or without a walker or walking cane for the purpose of research when in the 'ON' state

Exclusion Criteria

•A serious cognitive impairment (MMSE\<24)
•Pregnant or currently involved in another clinical trial.
•Pacemakers
•On opioid or neuropathic pain medication

Locations (1)

Participants' home in the Mid-West region of Ireland

Limerick, Ireland

Key Dates

Start Date

October 1, 2013

Primary Completion Date

November 30, 2020

Completion Date

November 30, 2020

Last Updated

September 18, 2020

Enrollment

ACTUAL participants

Conditions

Parkinson's Disease

Interventions

neuromuscular stimulation device

DEVICE

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

NCT07310264

Healthy Volunteers (HV)Parkinson's Disease (PD)

View study

RECRUITINGNA

Deep Brain Stimulation Therapy in Movement Disorders

NCT02119611

Parkinson's Disease

View study

RECRUITINGNA

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 18, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Electrical Stimulation for the Relief of Freezing of Gait (FOG) in Parkinson's Patients

Inclusion Criteria

Exclusion Criteria

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

Deep Brain Stimulation Therapy in Movement Disorders

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Effect of Striatal Temporal Interference Stimulation on Language Processing in Neurodegenerative Diseases

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations